首页> 外文会议>Design of Medical Devices Conference >Modification of the ASTM Platelet and Leukocyte Assay - Use of an Alternative and Clinically Relevant Anticoagulant: An In-vitro Hemocompatibility Assessment of Blood Contacting Medical Devices
【24h】

Modification of the ASTM Platelet and Leukocyte Assay - Use of an Alternative and Clinically Relevant Anticoagulant: An In-vitro Hemocompatibility Assessment of Blood Contacting Medical Devices

机译:ASTM血小板和白细胞测定的修饰 - 使用替代和临床相关的抗凝血剂:血液接触医疗器械的体外血液化评估

获取原文

摘要

The purpose of this test method is to assist in the determination of the thrombogenic potential of medical materials exposed to human whole blood. By evaluating surface-induced activation, platelet adherence to a material, and platelet and leukocyte depletion from blood, a material's potential for thrombus formation can be assessed. If a significant decrease in platelets and/or leukocytes is observed in whole blood when compared to a blank control, the tested material has the potential to induce an in-vivo thrombogenic response.
机译:该测试方法的目的是有助于确定暴露于人类全血的医疗材料的血栓形成潜力。 通过评估表面诱导的活化,血小板粘附到材料,血小板和白细胞耗竭的血液,可以评估材料的血栓形成的潜力。 如果与空白控制相比,在全血中观察到血小板和/或白细胞的显着降低,则测试材料具有诱导体内血栓形成反应的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号